Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJRS.L Regulatory News (JRS)

  • There is currently no data for JRS

Sanctions Update

1 Mar 2022 14:21

RNS Number : 2396D
JPMorgan Russian Securities PLC
01 March 2022
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN RUSSIAN SECURITIES PLC

 

Legal Entity Identifier: 549300II3MHI98ZLVH37

 

 

Update from the Board of JPMorgan Russian Securities plc

 

Further to JPMorgan Russian Securities plc's (the Company) announcement on 24th February 2022 regarding the US/EU/UK sanctions, the Board provides the following update:

 

Portfolio:

As at 28th February 2022, the Company's portfolio comprised holdings in locally listed stocks of 49.4%, which the Company is currently unable to trade due to recent restrictions. 40.1% of the Company's holdings are in ADR/GDRs, where trading is disrupted. 10.5% of the Company's assets are held in mostly US Dollar cash and cash equivalents.

The Company currently holds VTB Bank stocks which represented approximately 1.9% of the Company's portfolio as at 25th February 2022. The Company's Manager continues to monitor the impact of the developing sanctions regimes on these stocks.

 

Management Fees:

The Company's Manager has advised the Board of its intention to waive its management fee. The waiver will take effect following payment of the management fee to 28th February 2022 and will apply until further notice.

 

NAV:

The Company will continue to calculate and announce its unaudited NAV on a daily basis. Details of the methodology applied to the calculation of the unaudited NAV will be included in these announcements.

 

Dividends:

As previously announced, the Company will pay its final and first interim dividends to shareholders on 11th March 2022, as declared on 27th January 2022. However, the current sanctions and restrictions in Russia are expected to restrict the Company's ability to pay any further dividends until further notice. It remains the Company's intention to resume quarterly dividend payments once circumstances permit.

 

Share Buyback:

The Company will not be buying back shares whilst current market conditions prevail.

 

 

 

AGM:

The Board continues to recommend that shareholders vote in favour of the resolution for the continuation of the Company at the Annual General Meeting on 4th March 2022. The Board will monitor developments closely thereafter.

 

 

1st March 2022

 

For further information:

 

Paul Winship

Tim Mitchell

JPMorgan Funds Limited 020 7742 4000

 

Hugh Jonathan

Numis Securities plc 020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBSGDXCBGDGDB
Date   Source Headline
22nd Mar 202210:40 amRNSNet Asset Value(s)
21st Mar 20224:32 pmRNSHolding(s) in Company
21st Mar 202210:55 amRNSNet Asset Value(s)
18th Mar 20224:55 pmRNSUpdate from the Company
18th Mar 202212:07 pmRNSNet Asset Value(s)
17th Mar 20224:01 pmRNSHolding(s) in Company
17th Mar 202211:15 amRNSNet Asset Value(s)
16th Mar 20224:18 pmRNSHolding(s) in Company
16th Mar 20224:00 pmRNSTen Largest Investments
16th Mar 202211:33 amRNSNet Asset Value(s)
16th Mar 20229:29 amRNSHolding(s) in Company
15th Mar 202210:52 amRNSNet Asset Value(s)
14th Mar 202211:27 amRNSNet Asset Value(s)
11th Mar 202211:19 amRNSNet Asset Value(s)
10th Mar 20225:30 pmRNSHolding(s) in Company
10th Mar 202212:16 pmRNSNet Asset Value(s)
9th Mar 202211:40 amRNSNet Asset Value(s)
8th Mar 20225:03 pmRNSHolding(s) in Company
8th Mar 20225:01 pmRNSCompany Update
8th Mar 202211:36 amRNSNet Asset Value(s)
7th Mar 20221:08 pmRNSNet Asset Value(s)
4th Mar 20224:49 pmRNSResult of AGM
4th Mar 20224:31 pmRNSNet Asset Value(s)
3rd Mar 20225:40 pmRNSHolding(s) in Company
3rd Mar 20225:26 pmRNSNet Asset Value(s)
3rd Mar 20223:39 pmRNSUpdate on Proceedings at Annual General Meeting
2nd Mar 20225:24 pmRNSNet Asset Value(s)
1st Mar 20224:34 pmRNSNet Asset Value(s)
1st Mar 20222:21 pmRNSSanctions Update
1st Mar 20221:05 pmRNSDirectorate Change
28th Feb 202212:30 pmRNSGearing Announcement
28th Feb 202211:33 amRNSNet Asset Value(s)
25th Feb 20225:28 pmRNSSanctions
25th Feb 202211:35 amRNSNet Asset Value(s)
24th Feb 20222:53 pmRNSDirectorate Change
24th Feb 202211:40 amRNSNet Asset Value(s)
23rd Feb 202211:27 amRNSNet Asset Value(s)
22nd Feb 202211:25 amRNSNet Asset Value(s)
21st Feb 202211:45 amRNSGearing Announcement
21st Feb 202210:51 amRNSNet Asset Value(s)
18th Feb 202211:33 amRNSNet Asset Value(s)
17th Feb 202211:06 amRNSNet Asset Value(s)
16th Feb 202211:16 amRNSNet Asset Value(s)
15th Feb 202210:55 amRNSNet Asset Value(s)
14th Feb 20224:46 pmRNSTen Largest Investments
14th Feb 202211:59 amRNSGearing Announcement
14th Feb 202211:37 amRNSNet Asset Value(s)
11th Feb 202210:58 amRNSNet Asset Value(s)
10th Feb 202211:06 amRNSNet Asset Value(s)
9th Feb 20222:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.